Featured Research

from universities, journals, and other organizations

Cardiologists uncover new heart attack warning sign

Date:
January 18, 2011
Source:
University of Connecticut
Summary:
Cardiologist have identified a protein fragment that is a likely biomarker for heart attack.

Cardiologists at the University of Connecticut Health Center have identified a protein fragment that when detected in the blood can be a predictor of heart attack.

Their research, led by Dr. Bruce Liang, director of the Pat and Jim Calhoun Cardiology Center, is published in the January 11 issue of the Journal of the American College of Cardiology. It found heart attack patients had elevated levels of the protein fragment known as Caspase-3 p17 in their blood.

"We've discovered a new biomarker for heart attack, and showed that apoptosis, or a particular kind of cell death, is a cause of heart muscle damage." Liang says. "The ability to see a heart attack coming with a simple blood test and to develop new therapies to block apoptosis would enable us to get a head start on treatment and preserve crucial heart muscle and cardiac function."

If it is successfully applied one day, researchers say the discovery would mean another way to diagnose heart attack and the possible development of new treatment.

Co-investigators include Drs. Mariela Agosto, Michael Azrin and Kanwar Singh from the UConn Health Center and Dr. Allan Jaffe from the Mayo Clinic and Mayo Medical School, Rochester, Minnesota.


Story Source:

The above story is based on materials provided by University of Connecticut. Note: Materials may be edited for content and length.


Journal Reference:

  1. Mariela Agosto, Michael Azrin, Kanwar Singh, Allan S. Jaffe, Bruce T. Liang. Serum Caspase-3 p17 Fragment Is Elevated in Patients With ST-Segment Elevation Myocardial InfarctionA Novel Observation. Journal of the American College of Cardiology, 2011; 57 (2): 220 DOI: 10.1016/j.jacc.2010.08.628

Cite This Page:

University of Connecticut. "Cardiologists uncover new heart attack warning sign." ScienceDaily. ScienceDaily, 18 January 2011. <www.sciencedaily.com/releases/2011/01/110106070906.htm>.
University of Connecticut. (2011, January 18). Cardiologists uncover new heart attack warning sign. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2011/01/110106070906.htm
University of Connecticut. "Cardiologists uncover new heart attack warning sign." ScienceDaily. www.sciencedaily.com/releases/2011/01/110106070906.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins